Rezdiffra made headlines last year as the first drug cleared to treat MASH, with the FDA specifically clearing the drug in patients with stages F2 and F3 non-cirrhotic MASH. As the launch gains ...

Semaglutide shows promise in MASH treatment, achieving significant MASH resolution and fibrosis improvement in the ESSENCE trial. Tolerability issues and insurance coverage challenges lead to 20% ...

As of the end of March, more than 17,000 MASH patients were actively taking Rezdiffra, compared with more than 11,800 at year-end 2024, according to Madrigal. Rezdiffra’s speed of adding new ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions. By the end of ...

Get Instant Summarized Text (Gist) A bifunctional exosome-based drug delivery system was developed to target metabolic dysfunction-associated steatohepatitis (MASH). By engineering exosomes to ...

The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division semifinal best of five series following a pair of wins in Cleveland.

Adult patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or advanced liver fibrosis showed improved liver histology with a once-weekly dose of semaglutide (Wegovy ...

TAMPA, Fla. — It took a month, but this is the Phillies lineup that was advertised. The Phils pounded the Rays, 7-0, on Wednesday night at Steinbrenner Field to win their fourth straight series ...

Outcomes in patients with type 2 diabetes with MASH and MASLD: A comparison between bariatric surgery and GLP-1 agonists. Presented at: Digestive Disease Week; May 3-6, 2025; San Diego.

On potentially facing Liverpool one day in the future, McElhenney added: "One day I hope to mash their dreams into oblivion, but for now I celebrate along with Humphrey [Ker, Wrexham board member ...

"We're pleased to announce the dosing of first patient in our phase 2 study of DR10624 for the treatment of MASLD/MASH. Patients with MASLD face an increased risk of cardiovascular disease and type 2 ...

Actor Patrick Adiarte, best known for his role in Season 1 of revered 1970s comedy series M*A*S*H, has died at age 82. The Daily Mail newspaper reports that Adiarte’s niece confirmed the news ...